Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative esketamine infusion for recovery after arthroscopic rotator cuff repair
ChiCTR2500102085Phase 4Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of esketamine in Rotator cuff deficiency (RCD) (3 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Postoperative recovery quality on the first day. Started May 2025; status: recruiting.
02
Drugs
esketamine
03
Conditions
Rotator cuff deficiency (RCD)
Beyond the preview
Go deeper on ChiCTR2500102085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500102085.